ProfileGDS4718 / 205414_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 81% 82% 58% 83% 82% 69% 51% 84% 81% 81% 81% 81% 80% 50% 52% 82% 86% 61% 56% 24% 80% 82% 83% 85% 80% 72% 83% 32% 85% 43% 49% 57% 82% 82% 28% 63% 63% 80% 85% 45% 86% 55% 49% 49% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]7.9889981
GSM549102patient 115, normal, homogenized [OPG study]8.0382382
GSM549104patient 119, normal, homogenized [OPG study]6.0267258
GSM549108patient 138, normal, homogenized [OPG study]8.1397183
GSM549119patient 077, normal, homogenized [OPG study]8.0720182
GSM549133patient 032, cancer, homogenized [OPG study]6.7971269
GSM549139patient 042, cancer, homogenized [OPG study]5.5607751
GSM549099patient 107, normal, homogenized [OPG study]8.2142784
GSM549109patient 139, normal, homogenized [OPG study]7.8971781
GSM549110patient 046, normal, homogenized [OPG study]7.8943781
GSM549114patient 063, normal, homogenized [OPG study]8.0935181
GSM549122patient 082, normal, homogenized [OPG study]7.9490881
GSM549134patient 033, cancer, homogenized [OPG study]7.8471980
GSM549136patient 036, cancer, homogenized [OPG study]5.4893450
GSM549140patient 044, cancer, homogenized [OPG study]5.6302652
GSM549111patient 047, normal, homogenized [OPG study]8.0980782
GSM549113patient 057, normal, homogenized [OPG study]8.7610386
GSM549132patient 031, cancer, homogenized [OPG study]6.2144761
GSM549137patient 038, cancer, homogenized [OPG study]5.8678856
GSM549142patient 047, cancer, homogenized [OPG study]4.3820424
GSM549100patient 110, normal, homogenized [OPG study]7.7235580
GSM549107patient 135, normal, homogenized [OPG study]8.1118382
GSM549115patient 068, normal, homogenized [OPG study]8.3927683
GSM549116patient 072, normal, homogenized [OPG study]8.4744785
GSM549120patient 078, normal, homogenized [OPG study]7.879580
GSM549131patient 030, cancer, homogenized [OPG study]7.1824872
GSM549118patient 074, normal, homogenized [OPG study]8.262983
GSM549129patient 027, cancer, homogenized [OPG study]4.657132
GSM549123patient 088, normal, homogenized [OPG study]8.5410385
GSM549124patient 006, cancer, homogenized [OPG study]5.1979943
GSM549126patient 015, cancer, homogenized [OPG study]5.4171849
GSM549128patient 025, cancer, homogenized [OPG study]5.9331357
GSM549103patient 117, normal, homogenized [OPG study]7.9248682
GSM549117patient 073, normal, homogenized [OPG study]8.136382
GSM549138patient 041, cancer, homogenized [OPG study]4.4474228
GSM549141patient 045, cancer, homogenized [OPG study]6.3847563
GSM549130patient 028, cancer, homogenized [OPG study]6.3249263
GSM549101patient 111, normal, homogenized [OPG study]7.8454380
GSM549105patient 128, normal, homogenized [OPG study]8.3980285
GSM549106patient 134, normal, homogenized [OPG study]5.1667445
GSM549112patient 048, normal, homogenized [OPG study]8.6974986
GSM549125patient 011, cancer, homogenized [OPG study]5.7831855
GSM549127patient 024, cancer, homogenized [OPG study]5.4801549
GSM549135patient 035, cancer, homogenized [OPG study]5.4110549